Tumor chemotherapy and autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy21

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Mesenchymal Stromal Cells Bone Marrow Pluripotent Stem Cells T-Lymphocytes Bone Marrow Cells Neural Stem Cells Cells, Cultured Induced Pluripotent Stem Cells Multipotent Stem Cells Cell Line, Tumor Antilymphocyte Serum Fetal Stem Cells Neoplastic Stem Cells Fetal Blood Spermatogonia Cell Line

Organisms6

Transplantation Chimera Mice, Inbred C57BL Mice, SCID Mice, Inbred BALB C Cytomegalovirus Mice, Transgenic

Diseases56

Multiple Myeloma Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Neoplasm, Residual Lymphoma, Large B-Cell, Diffuse Leukemia, Myeloid, Acute Lymphoma, B-Cell Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Neoplasms, Second Primary Leukemia, Plasma Cell Neoplasm Recurrence, Local Leukemia, Myeloid Neoplasms Neutropenia Leukemia Disease Progression Breast Neoplasms Acute Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Neuroblastoma Lymphoma, AIDS-Related Hematologic Diseases Hepatic Veno-Occlusive Disease Stomatitis Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Mucositis Medulloblastoma Anemia, Aplastic Infection Chromosome Aberrations Central Nervous System Neoplasms Severe Combined Immunodeficiency Disease Models, Animal Thrombocytopenia Brain Neoplasms Lymphoproliferative Disorders Opportunistic Infections Leukemia, Lymphocytic, Chronic, B-Cell Bone Neoplasms Neoplasm Metastasis Postoperative Complications Lung Neoplasms Sarcoma, Ewing Liver Neoplasms Neoplasms, Experimental Paraproteinemias

Chemicals and Drugs50

Melphalan Etoposide Cyclophosphamide Myeloablative Agonists Cytarabine Carmustine Thiotepa Vincristine Doxorubicin Busulfan Boronic Acids Dexamethasone Pyrazines Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Alkylating Antigens, CD34 Antineoplastic Agents Thalidomide Ifosfamide Granulocyte Colony-Stimulating Factor Prednisone Podophyllotoxin Mitoxantrone Idarubicin Cisplatin Carboplatin Antibodies, Monoclonal Immunosuppressive Agents Keratins, Type II Immunoglobulin Light Chains Vidarabine Bleomycin HLA Antigens Tumor Markers, Biological Methotrexate Antilymphocyte Serum Immunoconjugates Recombinant Proteins Stem Cell Factor Tumor Necrosis Factor-alpha Cyclosporine Minor Histocompatibility Antigens Prednisolone Antigens, Neoplasm Antigens, CD Antigens, CD20 Immunologic Factors Biological Markers Nitrogen Mustard Compounds Tacrolimus

Analytical, Diagnostic and Therapeutic Techniques and Equipment91

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Treatment Outcome Remission Induction Salvage Therapy Disease-Free Survival Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Bone Marrow Purging Survival Analysis Whole-Body Irradiation Retrospective Studies Prognosis Follow-Up Studies Liver Transplantation Induction Chemotherapy Mesenchymal Stem Cell Transplantation Leukapheresis Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Infusions, Spinal Prospective Studies Chemotherapy, Adjuvant Blood Component Removal Histocompatibility Testing Feasibility Studies Drug Administration Schedule Fatal Outcome Neoplasm Staging Radioimmunotherapy Life Tables Risk Factors Immunotherapy Heart Transplantation Kaplan-Meier Estimate Clinical Trials as Topic Lung Transplantation Flow Cytometry Transplantation, Isogeneic Blood Transfusion, Autologous Organ Transplantation Lymphocyte Transfusion Treatment Failure Positron-Emission Tomography Pilot Projects Transplantation, Heterologous Immunosuppression Transplantation Islets of Langerhans Transplantation Predictive Value of Tests Lymphocyte Depletion Cell Separation Immunophenotyping Randomized Controlled Trials as Topic Platelet Count Pancreas Transplantation Multivariate Analysis Proportional Hazards Models Radiotherapy Tumor Burden Cell Culture Techniques Disease Models, Animal Severity of Illness Index Immunomagnetic Separation Donor Selection Immunohistochemistry Reverse Transcriptase Polymerase Chain Reaction Leukocyte Count Stem Cell Research Cohort Studies Drug Therapy Polymerase Chain Reaction Cell- and Tissue-Based Therapy Fetal Tissue Transplantation Immunotherapy, Adoptive Infusions, Intravenous Colony-Forming Units Assay Neoadjuvant Therapy Incidence Transplantation, Heterotopic Actuarial Analysis Neoplasms, Experimental

Psychiatry and Psychology1

Phenomena and Processes26

Graft Survival Time Factors Cell Differentiation Histocompatibility Hematopoiesis Graft vs Leukemia Effect Dose-Response Relationship, Drug Transplantation Immunology Stem Cell Niche Graft Rejection Graft vs Tumor Effect Chimerism Cell Proliferation Cell Lineage Platelet Count Chromosome Aberrations Regeneration Cell Survival Drug Resistance, Neoplasm Immunocompromised Host Leukocyte Count Transplantation Tolerance Virus Activation Cell Division Signal Transduction Phenotype

Disciplines and Occupations2

Immunohistochemistry Stem Cell Research

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Fatal Outcome Life Tables Incidence

Named Groups4

Tissue Donors Siblings Unrelated Donors Living Donors

Health Care25

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Feasibility Studies Fatal Outcome Life Tables Risk Factors Kaplan-Meier Estimate Clinical Trials as Topic Treatment Failure Pilot Projects Predictive Value of Tests Age Factors Randomized Controlled Trials as Topic Multivariate Analysis Proportional Hazards Models Severity of Illness Index Donor Selection Cohort Studies Incidence Actuarial Analysis

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Multiple Myeloma Antineoplastic Combined Chemotherapy Protocols Melphalan Transplantation, Homologous Transplantation Conditioning Combined Modality Therapy Treatment Outcome Remission Induction Stem Cells Salvage Therapy Disease-Free Survival Etoposide Hodgkin Disease Cyclophosphamide Lymphoma, Non-Hodgkin Myeloablative Agonists Recurrence Cytarabine Carmustine Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Graft vs Host Disease Thiotepa Vincristine Bone Marrow Purging Survival Analysis Hematologic Neoplasms Lymphoma, Mantle-Cell Whole-Body Irradiation Retrospective Studies Amyloidosis Doxorubicin Hematopoietic Stem Cells Prognosis Busulfan Boronic Acids Dexamethasone Pyrazines Graft Survival Follow-Up Studies Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Alkylating Lymphoma, Follicular Antigens, CD34 Autografts Lymphoma, T-Cell, Peripheral Liver Transplantation Antineoplastic Agents Thalidomide Ifosfamide Time Factors Induction Chemotherapy Lymphoma Mesenchymal Stem Cell Transplantation Granulocyte Colony-Stimulating Factor Leukapheresis Prednisone Podophyllotoxin Neoplasm, Residual Lymphoma, Large B-Cell, Diffuse Transplantation Chimera Maintenance Chemotherapy Tissue Donors Leukemia, Myeloid, Acute Cord Blood Stem Cell Transplantation Cell Transplantation Lymphoma, B-Cell Kidney Transplantation Embryonic Stem Cells Enteropathy-Associated T-Cell Lymphoma Myelodysplastic Syndromes Mitoxantrone Idarubicin Cisplatin Neoplasms, Second Primary Leukemia, Plasma Cell Infusions, Spinal Prospective Studies Neoplasm Recurrence, Local Carboplatin Antibodies, Monoclonal Adult Stem Cells Chemotherapy, Adjuvant Blood Component Removal Immunosuppressive Agents Histocompatibility Testing Feasibility Studies Drug Administration Schedule Cell Differentiation Fatal Outcome Leukemia, Myeloid Neoplasms Neoplasm Staging Radioimmunotherapy Keratins, Type II

No FAQ available that match "tumor chemotherapy and autologous stem cell transplantation"